BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Testicular cancer

1. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [